Atlas Trials

A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers

Clinical trial NCT03832426 · COMPLETED

Trial details

NCT number
NCT03832426
Sponsor
R-Pharm
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2013-11-08
Primary completion
2014-10-24
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.